Gill Benjamin, Tidwell Cody, Hagedorn Jonathan M, Moreira Alexandra M, Lawandy Marco, Boyett Benjamin, Schappell Justin, Latif Usman, Pritzlaff Scott, Skaribas Ioannis, Kalia Hemant, Sheth Samir, Schnur Maricela, Li Sean, Lester Denise, Ellico Trevor, Naidu Ramana, Russo David, Massey Christopher, Ottestad Einar, Vorenkamp Kevin, Vucetic Henry, Pingree Matthew J, Abejón David, Desai Mehul J, Dickerson David, Gulati Amitabh, Sayed Dawood, Deer Timothy R
Omaha Pain Physicians, Omaha, NE, USA.
Department of Anesthesiology and Pain Medicine, University of Minnesota, Minneapolis, MN, USA.
J Pain Res. 2025 Jun 24;18:3117-3139. doi: 10.2147/JPR.S521788. eCollection 2025.
Peripheral nerve stimulation (PNS) has evolved with various applications and durations of therapy. In recent years, extensive data has been developed on a 60-day treatment using a novel approach. Confusion exists on the use of a trial therapy, a permanent implant, and a 60-day duration treatment. The American Society of Pain and Neuroscience (ASPN) seeks to clarify the literature associated with this neuromodulation approach. A diverse group of experts was nominated to provide opinions and guidance based on evidence-graded assessment and clinical knowledge. This guidance is the first to specifically assess the clinical use of 60-day PNS and best medical practice.
外周神经刺激（PNS）随着治疗的各种应用和持续时间不断发展。近年来，关于采用一种新方法进行60天治疗已积累了大量数据。在试验性治疗、永久性植入以及60天疗程治疗的使用方面存在困惑。美国疼痛与神经科学学会（ASPN）试图澄清与这种神经调节方法相关的文献。一个多元化的专家小组被提名，以基于循证分级评估和临床知识提供意见和指导。该指导首次专门评估60天PNS的临床应用及最佳医疗实践。
